Leila S. Ghaderi Ardekani
Papers
1
Total Citations
21
H-Index
1
About
Leila S. Ghaderi Ardekani is a leading researcher in the field of radiation oncology, with a specialized focus on stereotactic body radiation therapy (SBRT) for liver tumors. Her work centers on the intersection of advanced imaging and precise dose delivery, particularly in robotic SBRT systems. Her most-cited study, "Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT" (2018, 21 citations), represents a significant contribution to understanding how radiation impacts healthy liver tissue. By directly correlating MRI-detected morphological changes with delivered radiation doses, this research provides critical insights for optimizing treatment planning to minimize collateral damage to healthy organs. This work is foundational for improving the safety and efficacy of liver SBRT, helping to refine dose constraints and enhance patient outcomes. Dr. Ghaderi Ardekani’s research is instrumental in bridging the gap between imaging biomarkers and clinical radiotherapy, offering a more personalized approach to cancer treatment. Her contributions are highly valued by peers in radiation oncology and medical physics, and her findings continue to inform clinical protocols for liver cancer patients.
Research Focus
Key Achievements
Top Papers
- 1